Published in Hepatitis Weekly, October 30th, 2000
Lamivudine has been used to treat patients with HBV for several years now. Unfortunately, some HBV virus strains have acquired mutations that make them non-susceptible to the drug that has been a mainstay for treating HBV patients.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.